nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.00428	0.00428	CcSEcCtD
Verteporfin—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00426	0.00426	CcSEcCtD
Verteporfin—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.00419	0.00419	CcSEcCtD
Verteporfin—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00412	0.00412	CcSEcCtD
Verteporfin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00408	0.00408	CcSEcCtD
Verteporfin—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.00404	0.00404	CcSEcCtD
Verteporfin—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00402	0.00402	CcSEcCtD
Verteporfin—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00399	0.00399	CcSEcCtD
Verteporfin—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00397	0.00397	CcSEcCtD
Verteporfin—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00392	0.00392	CcSEcCtD
Verteporfin—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00392	0.00392	CcSEcCtD
Verteporfin—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00385	0.00385	CcSEcCtD
Verteporfin—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00384	0.00384	CcSEcCtD
Verteporfin—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00382	0.00382	CcSEcCtD
Verteporfin—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.00381	0.00381	CcSEcCtD
Verteporfin—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00381	0.00381	CcSEcCtD
Verteporfin—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00375	0.00375	CcSEcCtD
Verteporfin—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00375	0.00375	CcSEcCtD
Verteporfin—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00373	0.00373	CcSEcCtD
Verteporfin—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00372	0.00372	CcSEcCtD
Verteporfin—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00371	0.00371	CcSEcCtD
Verteporfin—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.0037	0.0037	CcSEcCtD
Verteporfin—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00368	0.00368	CcSEcCtD
Verteporfin—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00367	0.00367	CcSEcCtD
Verteporfin—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00367	0.00367	CcSEcCtD
Verteporfin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00366	0.00366	CcSEcCtD
Verteporfin—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00363	0.00363	CcSEcCtD
Verteporfin—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00363	0.00363	CcSEcCtD
Verteporfin—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00363	0.00363	CcSEcCtD
Verteporfin—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00362	0.00362	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00361	0.00361	CcSEcCtD
Verteporfin—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Verteporfin—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00357	0.00357	CcSEcCtD
Verteporfin—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00357	0.00357	CcSEcCtD
Verteporfin—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.0035	0.0035	CcSEcCtD
Verteporfin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00349	0.00349	CcSEcCtD
Verteporfin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00349	0.00349	CcSEcCtD
Verteporfin—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00348	0.00348	CcSEcCtD
Verteporfin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00347	0.00347	CcSEcCtD
Verteporfin—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00346	0.00346	CcSEcCtD
Verteporfin—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00346	0.00346	CcSEcCtD
Verteporfin—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00344	0.00344	CcSEcCtD
Verteporfin—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00344	0.00344	CcSEcCtD
Verteporfin—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00342	0.00342	CcSEcCtD
Verteporfin—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00341	0.00341	CcSEcCtD
Verteporfin—Arthropathy—Prednisone—chronic obstructive pulmonary disease	0.00341	0.00341	CcSEcCtD
Verteporfin—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00339	0.00339	CcSEcCtD
Verteporfin—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00338	0.00338	CcSEcCtD
Verteporfin—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00337	0.00337	CcSEcCtD
Verteporfin—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00333	0.00333	CcSEcCtD
Verteporfin—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00333	0.00333	CcSEcCtD
Verteporfin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00329	0.00329	CcSEcCtD
Verteporfin—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.00328	0.00328	CcSEcCtD
Verteporfin—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00327	0.00327	CcSEcCtD
Verteporfin—Cataract—Prednisone—chronic obstructive pulmonary disease	0.00325	0.00325	CcSEcCtD
Verteporfin—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00325	0.00325	CcSEcCtD
Verteporfin—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00324	0.00324	CcSEcCtD
Verteporfin—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00319	0.00319	CcSEcCtD
Verteporfin—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00319	0.00319	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00317	0.00317	CcSEcCtD
Verteporfin—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00314	0.00314	CcSEcCtD
Verteporfin—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.0031	0.0031	CcSEcCtD
Verteporfin—Malaise—Formoterol—chronic obstructive pulmonary disease	0.0031	0.0031	CcSEcCtD
Verteporfin—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.00309	0.00309	CcSEcCtD
Verteporfin—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00301	0.00301	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.003	0.003	CcSEcCtD
Verteporfin—Cough—Arformoterol—chronic obstructive pulmonary disease	0.003	0.003	CcSEcCtD
Verteporfin—Cough—Formoterol—chronic obstructive pulmonary disease	0.003	0.003	CcSEcCtD
Verteporfin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00298	0.00298	CcSEcCtD
Verteporfin—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00297	0.00297	CcSEcCtD
Verteporfin—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00297	0.00297	CcSEcCtD
Verteporfin—Cough—Montelukast—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Verteporfin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00293	0.00293	CcSEcCtD
Verteporfin—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00293	0.00293	CcSEcCtD
Verteporfin—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00293	0.00293	CcSEcCtD
Verteporfin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00293	0.00293	CcSEcCtD
Verteporfin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00293	0.00293	CcSEcCtD
Verteporfin—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00293	0.00293	CcSEcCtD
Verteporfin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00292	0.00292	CcSEcCtD
Verteporfin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00292	0.00292	CcSEcCtD
Verteporfin—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00291	0.00291	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00291	0.00291	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00291	0.00291	CcSEcCtD
Verteporfin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00289	0.00289	CcSEcCtD
Verteporfin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00289	0.00289	CcSEcCtD
Verteporfin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00287	0.00287	CcSEcCtD
Verteporfin—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00286	0.00286	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00285	0.00285	CcSEcCtD
Verteporfin—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00284	0.00284	CcSEcCtD
Verteporfin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00281	0.00281	CcSEcCtD
Verteporfin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00281	0.00281	CcSEcCtD
Verteporfin—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00281	0.00281	CcSEcCtD
Verteporfin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00277	0.00277	CcSEcCtD
Verteporfin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00277	0.00277	CcSEcCtD
Verteporfin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00276	0.00276	CcSEcCtD
Verteporfin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00275	0.00275	CcSEcCtD
Verteporfin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00275	0.00275	CcSEcCtD
Verteporfin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00275	0.00275	CcSEcCtD
Verteporfin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00273	0.00273	CcSEcCtD
Verteporfin—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00273	0.00273	CcSEcCtD
Verteporfin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00273	0.00273	CcSEcCtD
Verteporfin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00273	0.00273	CcSEcCtD
Verteporfin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
Verteporfin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.0027	0.0027	CcSEcCtD
Verteporfin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00267	0.00267	CcSEcCtD
Verteporfin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00265	0.00265	CcSEcCtD
Verteporfin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00261	0.00261	CcSEcCtD
Verteporfin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00261	0.00261	CcSEcCtD
Verteporfin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.0026	0.0026	CcSEcCtD
Verteporfin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00258	0.00258	CcSEcCtD
Verteporfin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Verteporfin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00251	0.00251	CcSEcCtD
Verteporfin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.0025	0.0025	CcSEcCtD
Verteporfin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.0025	0.0025	CcSEcCtD
Verteporfin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00246	0.00246	CcSEcCtD
Verteporfin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00244	0.00244	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00242	0.00242	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00242	0.00242	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.00242	CcSEcCtD
Verteporfin—Pain—Formoterol—chronic obstructive pulmonary disease	0.0024	0.0024	CcSEcCtD
Verteporfin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.0024	0.0024	CcSEcCtD
Verteporfin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.0024	0.0024	CcSEcCtD
Verteporfin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.0024	0.0024	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00237	0.00237	CcSEcCtD
Verteporfin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00236	0.00236	CcSEcCtD
Verteporfin—Pain—Montelukast—chronic obstructive pulmonary disease	0.00235	0.00235	CcSEcCtD
Verteporfin—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00235	0.00235	CcSEcCtD
Verteporfin—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00234	0.00234	CcSEcCtD
Verteporfin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00233	0.00233	CcSEcCtD
Verteporfin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00232	0.00232	CcSEcCtD
Verteporfin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00232	0.00232	CcSEcCtD
Verteporfin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00231	0.00231	CcSEcCtD
Verteporfin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00231	0.00231	CcSEcCtD
Verteporfin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00231	0.00231	CcSEcCtD
Verteporfin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.0023	0.0023	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00229	0.00229	CcSEcCtD
Verteporfin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00227	0.00227	CcSEcCtD
Verteporfin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00227	0.00227	CcSEcCtD
Verteporfin—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00225	0.00225	CcSEcCtD
Verteporfin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00223	0.00223	CcSEcCtD
Verteporfin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00223	0.00223	CcSEcCtD
Verteporfin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00222	0.00222	CcSEcCtD
Verteporfin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00222	0.00222	CcSEcCtD
Verteporfin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Verteporfin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Verteporfin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Verteporfin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Verteporfin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Verteporfin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00218	0.00218	CcSEcCtD
Verteporfin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00217	0.00217	CcSEcCtD
Verteporfin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00215	0.00215	CcSEcCtD
Verteporfin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00214	0.00214	CcSEcCtD
Verteporfin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00211	0.00211	CcSEcCtD
Verteporfin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.0021	0.0021	CcSEcCtD
Verteporfin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00207	0.00207	CcSEcCtD
Verteporfin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00207	0.00207	CcSEcCtD
Verteporfin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00207	0.00207	CcSEcCtD
Verteporfin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00206	0.00206	CcSEcCtD
Verteporfin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00203	0.00203	CcSEcCtD
Verteporfin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00202	0.00202	CcSEcCtD
Verteporfin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00202	0.00202	CcSEcCtD
Verteporfin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00199	0.00199	CcSEcCtD
Verteporfin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00199	0.00199	CcSEcCtD
Verteporfin—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.00198	0.00198	CcSEcCtD
Verteporfin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00197	0.00197	CcSEcCtD
Verteporfin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.00195	CcSEcCtD
Verteporfin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00195	0.00195	CcSEcCtD
Verteporfin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.0019	0.0019	CcSEcCtD
Verteporfin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00188	0.00188	CcSEcCtD
Verteporfin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00186	0.00186	CcSEcCtD
Verteporfin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00186	0.00186	CcSEcCtD
Verteporfin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00182	0.00182	CcSEcCtD
Verteporfin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00177	CcSEcCtD
Verteporfin—Rash—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00177	CcSEcCtD
Verteporfin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00177	CcSEcCtD
Verteporfin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00177	CcSEcCtD
Verteporfin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00176	0.00176	CcSEcCtD
Verteporfin—Headache—Formoterol—chronic obstructive pulmonary disease	0.00176	0.00176	CcSEcCtD
Verteporfin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00176	0.00176	CcSEcCtD
Verteporfin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00175	0.00175	CcSEcCtD
Verteporfin—Rash—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00173	CcSEcCtD
Verteporfin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00173	CcSEcCtD
Verteporfin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00173	0.00173	CcSEcCtD
Verteporfin—Headache—Montelukast—chronic obstructive pulmonary disease	0.00172	0.00172	CcSEcCtD
Verteporfin—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00171	0.00171	CcSEcCtD
Verteporfin—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.0017	0.0017	CcSEcCtD
Verteporfin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00168	0.00168	CcSEcCtD
Verteporfin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Verteporfin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Verteporfin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Verteporfin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Verteporfin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Verteporfin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Verteporfin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00166	0.00166	CcSEcCtD
Verteporfin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00164	0.00164	CcSEcCtD
Verteporfin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00163	0.00163	CcSEcCtD
Verteporfin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00161	0.00161	CcSEcCtD
Verteporfin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00158	CcSEcCtD
Verteporfin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00157	0.00157	CcSEcCtD
Verteporfin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00156	0.00156	CcSEcCtD
Verteporfin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00156	0.00156	CcSEcCtD
Verteporfin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00152	0.00152	CcSEcCtD
Verteporfin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.0015	0.0015	CcSEcCtD
Verteporfin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00147	0.00147	CcSEcCtD
Verteporfin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00145	0.00145	CcSEcCtD
Verteporfin—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00144	0.00144	CcSEcCtD
Verteporfin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00141	CcSEcCtD
Verteporfin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00141	CcSEcCtD
Verteporfin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Verteporfin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.0013	0.0013	CcSEcCtD
Verteporfin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Verteporfin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00126	CcSEcCtD
Verteporfin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Verteporfin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Verteporfin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00122	CcSEcCtD
Verteporfin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00122	CcSEcCtD
Verteporfin—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00121	0.00121	CcSEcCtD
Verteporfin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00121	0.00121	CcSEcCtD
Verteporfin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00119	0.00119	CcSEcCtD
Verteporfin—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00117	0.00117	CcSEcCtD
Verteporfin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Verteporfin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00114	CcSEcCtD
Verteporfin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00112	CcSEcCtD
Verteporfin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Verteporfin—Shock—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Verteporfin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Verteporfin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Verteporfin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00101	CcSEcCtD
Verteporfin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00101	CcSEcCtD
Verteporfin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000959	0.000959	CcSEcCtD
Verteporfin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000958	0.000958	CcSEcCtD
Verteporfin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000953	0.000953	CcSEcCtD
Verteporfin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000945	0.000945	CcSEcCtD
Verteporfin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000911	0.000911	CcSEcCtD
Verteporfin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000903	0.000903	CcSEcCtD
Verteporfin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000878	0.000878	CcSEcCtD
Verteporfin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000874	0.000874	CcSEcCtD
Verteporfin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000814	0.000814	CcSEcCtD
Verteporfin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000793	0.000793	CcSEcCtD
Verteporfin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000782	0.000782	CcSEcCtD
Verteporfin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000731	0.000731	CcSEcCtD
Verteporfin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000697	0.000697	CcSEcCtD
Verteporfin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000696	0.000696	CcSEcCtD
Verteporfin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000692	0.000692	CcSEcCtD
Verteporfin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000657	0.000657	CcSEcCtD
